**Molecular Mechanism and Rationale**
The pathophysiological foundation of this therapeutic approach centers on the dysregulated activity of neutral sphingomyelinase-2 (nSMase2), encoded by the SMPD3 gene, which catalyzes the hydrolysis of sphingomyelin to ceramide and phosphocholine at the plasma membrane. Unlike its lysosomal counterpart acid sphingomyelinase (ASMase/SMPD1), nSMase2 operates optimally at physiological pH and is strategically positioned at the cell surface where it responds to
## Mechanistic Overview
Senescent Cell ASM-Complement Cascade Intervention starts from the claim that modulating SMPD1 within the disease context of neurodegeneration can redirect a disease-relevant process. The original description reads: "## Mechanistic Overview Senescent Cell ASM-Complement Cascade Intervention starts from the claim that modulating SMPD1 within the disease context of neurodegeneration can redirect a disease-relevant process. The original description reads: "## Molecular Mecha
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
Neuroinflammationneurodegeneration
Convergent signals
No same-target convergence detected in this selection.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Based on my research, here are 7 novel therapeutic hypotheses targeting lipid raft-mediated neurodegeneration:
## 1. Selective Acid Sphingomyelinase Modulation Therapy
**Description:** Partial inhibi...
Persona-Theorist
Based on my research, here are 7 novel therapeutic hypotheses targeting lipid raft-mediated neurodegeneration:
## 1. Selective Acid Sphingomyelinase Modulation Therapy
**Description:** Partial inhibi...
Persona-Theorist
Based on the provided literature on lipid raft composition changes in neurodegeneration, here are 7 novel therapeutic hypotheses:
## Hypothesis 1: Cholesterol-Sphingolipid Ratio Modulators as Synapti...
Based on my research, here are 7 novel therapeutic hypotheses targeting lipid raft-mediated neurodegeneration:
## 1. Selective Acid Sphingomyelinase Modulation Therapy
**Description:** Partial inhibi...
Persona-Theorist
Based on my research, here are 7 novel therapeutic hypotheses targeting lipid raft-mediated neurodegeneration:
## 1. Selective Acid Sphingomyelinase Modulation Therapy
**Description:** Partial inhibi...
Persona-Theorist
Based on the provided literature on lipid raft composition changes in neurodegeneration, here are 7 novel therapeutic hypotheses:
## Hypothesis 1: Cholesterol-Sphingolipid Ratio Modulators as Synapti...